AB Science CEO Discusses New Early-Treatment Drug For Covid-19 | Interview
2 years ago
1
Join The Conversation! | https://trialsitenews.com/
Alain Moussy, CEO of AB Science, discusses their new early-treatment drug for COVID-19:
AB Science | https://www.ab-science.com/
Article on drug published in Science | https://www.science.org/doi/10.1126/science.abg5827
Loading comments...
-
1:36
LotsaVids
1 year agoDR Ben Carson talks about covid, the jab, and alternatve treatments like Ivermectin and others
16 -
58:02
Prevent Global Genocide
10 months agoCorona Committee interviews Dr. Rodger Hodkinson concerning the covid jab
55 -
4:05
RVM News
1 year agoPfizer CEO Surprised He Got COVID 2X In 2 Months, Claims Jab Was Effective Until Omicron
29212 -
0:45
TheFreeMindMovement
1 year agoPFIZER CEO admits COVID19 jab was not tested
16 -
3:11
One America News Network
2 years agoDr. Marik: Doctors are targeted for prescribing off label meds for COVID-19
2.91K25 -
1:17:32
Medical Truth Podcast
11 months agoLooking Back at COVID Treatments 3 Years Later - Interview with Dr. Alan Bain
347 -
0:55
Newsy
3 years agoFirst COVID Drug Trials To Be Released In Two Weeks, WHO Director Says
4.48K -
11:36
Right2Freedom
1 year agoDr. Sam Bailey - Interview Highlights: COVID Era
70 -
1:27
🕷️ CABAL ELITES NWO 🕷️
1 year agoPfizer’s CEO, Albert Bourla, Is Asked If People Will Have To Take A Covid Shot Every Year:
404 -
17:15
thekalonu
1 year agoBREAKING NEWS: The FDA was involved in the development of Covid-19
6642